These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Inotropic effect of novel domestic cardiotonic agent, vesnarinone--test in vitro]. Han W; Qin Y; Zhang Z; Zhou S; Yang Z Hua Xi Yi Ke Da Xue Xue Bao; 1994 Sep; 25(3):316-20. PubMed ID: 7896252 [TBL] [Abstract][Full Text] [Related]
24. Effects of MCI-154 on calcium sensitivity of contractile system and calcium release from sarcoplasmic reticulum in saponin-skinned rat myocardium. Huang Y; He ZH; Li YX Zhongguo Yao Li Xue Bao; 1997 May; 18(3):234-7. PubMed ID: 10072940 [TBL] [Abstract][Full Text] [Related]
26. Mechanisms of positive inotropic action of flosequinan, hydralazine, and milrinone on mammalian myocardium. Miao L; Perreault CL; Travers KE; Morgan JP Eur J Pharmacol; 1997 Feb; 321(2):201-8. PubMed ID: 9063689 [TBL] [Abstract][Full Text] [Related]
27. The inotropic effects of amrinone and milrinone on neonatal and young canine cardiac muscle. Binah O; Sodowick B; Vulliemoz Y; Danilo P; Rosen M Circulation; 1986 Mar; 73(3 Pt 2):III46-51. PubMed ID: 3002663 [TBL] [Abstract][Full Text] [Related]
28. Effects of [Na+] and [Ca2+] on the responses to milrinone in rat cardiac preparations. Goyal RK; McNeill JH Eur J Pharmacol; 1986 Jan; 120(3):267-74. PubMed ID: 3948922 [TBL] [Abstract][Full Text] [Related]
29. Studies on the mechanism of action of the bipyridine milrinone on the heart. Farah AE; Frangakis CJ Basic Res Cardiol; 1989; 84 Suppl 1():85-103. PubMed ID: 2554875 [TBL] [Abstract][Full Text] [Related]
30. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 1st communication: studies on isolated guinea pig cardiac muscles. Ogawa T; Ohhara H; Tsunoda H; Kuroki J; Shoji T Arzneimittelforschung; 1989 Jan; 39(1):33-7. PubMed ID: 2566308 [TBL] [Abstract][Full Text] [Related]
31. Cardiac profile of EGIS-9377, a novel cardiotonic agent as a Ca2+ sensitizer with bradycardiac activity. Hattori Y; Ishitani T; Tomita F; Gando S; Yokoshiki H; Azuma M; Kemmotsu O; Kanno M Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):585-90. PubMed ID: 10598798 [TBL] [Abstract][Full Text] [Related]
32. Cardiotonic action of [8]-gingerol, an activator of the Ca++-pumping adenosine triphosphatase of sarcoplasmic reticulum, in guinea pig atrial muscle. Kobayashi M; Ishida Y; Shoji N; Ohizumi Y J Pharmacol Exp Ther; 1988 Aug; 246(2):667-73. PubMed ID: 2457078 [TBL] [Abstract][Full Text] [Related]
33. Effects of Levosimendan, a cardiotonic agent targeted to troponin C, on cardiac function and on phosphorylation and Ca2+ sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart. Edes I; Kiss E; Kitada Y; Powers FM; Papp JG; Kranias EG; Solaro RJ Circ Res; 1995 Jul; 77(1):107-13. PubMed ID: 7788868 [TBL] [Abstract][Full Text] [Related]
34. In-vivo effects of amrinone and milrinone on left ventricular dP/dt, intraventricular pressure and heart rate in pentobarbital-anesthetized guinea pigs. Lin BB; Chen HL Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):237-40. PubMed ID: 1811284 [TBL] [Abstract][Full Text] [Related]
35. Comparison of the effects of MCI-154, a new cardiotonic agent, and some Ca2+-sensitizing agents on the response of the contractile system to Ca2+ in skinned cardiac muscle. Kitada Y; Morita M; Narimatsu A Jpn J Pharmacol; 1989 Aug; 50(4):411-9. PubMed ID: 2789299 [TBL] [Abstract][Full Text] [Related]
36. Changes in membrane potentials and currents of ventricular cells of the guinea pig heart by a new cardiotonic drug, MCI-154. Katayama S; Narimatsu A; Suzuki R; Iijima T; Taira N Jpn J Pharmacol; 1987 Aug; 44(4):481-8. PubMed ID: 3682412 [TBL] [Abstract][Full Text] [Related]
37. The positive inotropic response to milrinone in isolated human and guinea pig myocardium. Brown L; Näbauer M; Erdmann E Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):196-201. PubMed ID: 3024033 [TBL] [Abstract][Full Text] [Related]
38. The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan. Haikala H; Kaheinen P; Levijoki J; Lindén IB Cardiovasc Res; 1997 Jun; 34(3):536-46. PubMed ID: 9231037 [TBL] [Abstract][Full Text] [Related]
39. Improvement of postischemic contractile dysfunction of dog heart by MCI-154, a novel cardiotonic agent. Abe Y; Kitada Y; Narimatsu A; Tobe A Eur J Pharmacol; 1991 Jan; 192(2):279-85. PubMed ID: 2032560 [TBL] [Abstract][Full Text] [Related]
40. The effects of milrinone and piroximone on intracellular calcium handling in working myocardium from the ferret. Gwathmey JK; Morgan JP Br J Pharmacol; 1985 May; 85(1):97-108. PubMed ID: 2992656 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]